-
Shufeng Xingbi Therapy in Allergic Rhinitis Rats
2026-09-23
This preprint examines Shufeng Xingbi Therapy as a combined intervention for ovalbumin-induced allergic rhinitis in rats, linking nasal inflammation with intestinal microbiota, serum short-chain fatty acids, and Th1/Th2-associated signaling. Its main contribution is an integrated experimental framework, although the antibiotic-treated design and preprint status limit causal and translational interpretation.
-
Neuromedin S (rat): GPCR Assay Guide
2026-09-23
Neuromedin S (rat), SKU B5466, provides a defined rat peptide input for controlled neuromedin U receptor and GPCR/G protein signaling experiments. It is intended for validated research workflows only; potency, efficacy, diagnostic, therapeutic, and cross-species claims should not be inferred without additional evidence.
-
Neuromedin S (rat): GPCR Workflow Guide
2026-09-22
Neuromedin S (rat), SKU B5466, provides a chemically defined peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein signaling assays. This guide covers preparation, controls, storage, and troubleshooting; the reagent is for research use only and is not validated for diagnostic, therapeutic, or medical applications.
-
Coumestrol Workflow for RA-FLS Ferroptosis
2026-09-21
Coumestrol connects estrogen-receptor pharmacology with a practical ferroptosis workflow in rheumatoid arthritis fibroblast-like synoviocytes. This guide translates the TRIM3–PMAIP1 finding into formulation controls, orthogonal assays, and troubleshooting decisions for reproducible cell-based research.
-
Temafloxacin Activity Against Gram-Negative Bacteria
2026-09-21
Hardy’s 1991 overview compared the in vitro activity of temafloxacin with ciprofloxacin and ofloxacin across respiratory, enteric, sexually transmitted, and opportunistic Gram-negative pathogens. Its main contribution was an organism-resolved susceptibility profile showing strong activity against many respiratory and enteric bacteria, but weaker performance against Pseudomonas aeruginosa than ciprofloxacin.
-
Linagliptin (BI-1356) in Translational Tau Assays
2026-09-20
Use Linagliptin (BI-1356) as an exploratory perturbation in tau-focused workflows without treating it as a substitute for the NUAK inhibitor tested in the reference study. The strongest design pairs human or mouse brain models with p-tau Ser356, total tau, neuronal, synaptic, and viability readouts to distinguish target-specific changes from tissue injury.
-
Aureonitol as a Fungal-Derived Herbicide Candidate
2026-09-19
Song and colleagues identified aureonitol from Chaetomium coarctatum NEAU-Z3 as an active natural-product herbicide against four weed species and linked its activity to reactive oxygen species accumulation, redox disruption, and broad transcriptomic changes. The study combines efficacy, crop-safety, and molecular evidence, while also defining the additional validation needed before aureonitol can progress toward practical bioherbicide development.
-
Bradykinin Workflows for Vascular Mechanism Studies
2026-09-19
Build reproducible assays for endothelial relaxation, vascular permeability modulation, and smooth muscle contraction research with Bradykinin. This workflow-focused guide also shows how to borrow multi-readout logic from a diabetic cognitive dysfunction study without confusing mechanistic analogy with direct evidence.
-
SmCPK24 Links Calcium Signaling to Tanshinones
2026-09-18
A genome-wide study identified 25 calcium-dependent protein kinase genes in Salvia miltiorrhiza and showed that SmCPK24 promotes tanshinone accumulation. The work defines a SmCPK24–SmWRKY1–SmDXS2 regulatory module that connects calcium signaling with specialized metabolism and offers a mechanistic framework for improving medicinal-plant metabolite production.
-
Trelagliptin succinate in Adipocyte Research
2026-09-18
Trelagliptin succinate, also known as SYR-472 succinate, connects selective DPP-4 enzyme inhibition with measurable PI3K/Akt/GLUT4 responses in adipocyte models. This practical guide translates the reference study into assay-ready workflows, formulation controls, troubleshooting steps, and carefully bounded extensions into metabolic and inflammatory research.
-
NU7441 (KU-57788) DNA-PK Workflow Guide
2026-09-17
Build reproducible DNA repair and oncology experiments with NU7441 (KU-57788), from DMSO handling and DNA-damage sensitization to cell-cycle profiling. The workflow emphasizes selective target interpretation, orthogonal readouts, and troubleshooting for cell-based and translational studies.
-
Streptavidin-HyperFluor 647 Workflow Guide
2026-09-17
Streptavidin-HyperFluor 647 combines high-specificity biotin capture with far-red fluorescence for microscopy, flow cytometry, and assay quality control. This guide shows how to integrate the Streptavidin fluorescent conjugate into antibody, nucleic-acid, and proximity-labeling workflows while distinguishing biotin-dependent detection from newer biotin-free strategies.
-
Elobixibat hydrate: IBAT Assay Workflows
2026-09-16
Learn how Elobixibat hydrate can be incorporated into ex vivo motility, bile acid signaling, constipation, bowel-preparation, and metabolic research workflows. A guinea pig ileum study provides a practical framework for separating peristaltic reflex modulation from direct smooth-muscle effects.
-
EdU Imaging Kits (488): S-Phase Detection
2026-09-15
EdU Imaging Kits (488) use 5-ethynyl-2'-deoxyuridine to label DNA synthesis during S phase through copper-catalyzed click chemistry. The K1175 workflow supports fluorescence microscopy and flow cytometry while avoiding the DNA-denaturation step required by many BrdU assays.
-
Talabostat mesylate: FAP and DPP4 Workflows
2026-09-15
Talabostat mesylate enables paired studies of FAP-positive tumor biology, DPP4-linked immune signaling, and cytokine responses in vitro and in vivo. This workflow-focused guide emphasizes target validation, pathway-separated controls, formulation discipline, and the important distinction between FAP/DPP4 assays and DPP8/9-driven inflammasome experiments.